Medical visa to India for residents of Algeria

Medical visa to India from Algeria
Check details on how to obtain medical visa to India from Algeria. Medical visa to India for residents of Algeria. Patients travelling from Algiers to India for treatment to connect with +91 96 1588 1588 for details & visa.

Share This Post

Medical visa to India for residents of Algeria can be given to patients who wishes to take medical treatment in India. Below mentioned is the complete details and procedure.

  • CancerFax helps in getting medical visa for medical treatment. Visa is granted up to one year with triple entries provided that registration is required after the patient reaches the country.
  • If one seeks medical treatment in top specialized/recognized  hospitals of India.
  • Up to  two attendants can accompany the patient who are closely related with him/her under separate attendant visas whose visa validity will be the same as the medical visa

Serious ailments like neurosurgery; ophthalmic disorders; heart – related problems; renal disorders; organ transplantation; congenital disorders; gene therapy; radio therapy; plastic surgery; joint replacement, etc. will be of primary consideration.
Document required for visa application

  • Indian visa application form.
  • Completed application form for India will be prepared within 5 business hours of order submission, and emailed to you to download, print and sign. IMPORTANT: Please note that ALL 3 PAGES of your application require your original signature! Also please note that each page of your application must be printed SINGLE-SIDED only. Applications printed/signed double-sided will be rejected. 
  • Original, signed Algeria passport with at least 6 months of remaining validity. 
  • Passport Photo: 1 Include a passport style photo, with a white background, taken within the last 6 months. You may also choose to upload a photo to your order for us to print. There is a surcharge associated with this service. 
  • Proof of status. Copy of Green Card (both sides) or other proof of legal status in the US (such as copy of I-20, US visa, H1B approval notice, etc. VisaHQ cannot assist US B1/B2 visa holders at this time.) 
  • Address in Algeria. If the traveler no longer maintains a residence in Algeria, they may provide their most recent residential address or the address of a relative. 
  • Driver’s license. Copy of driver’s license or state issued ID, or ORIGINAL major utility bill (Water, Gas, Electric, Sewage) for the most recent month, showing the applicant’s name and current address. The address must not contain a PO Box. Address MUST match home address in your applicant profile. 
  • Declaration Form. An original signed copy of the India Declaration Form. 

Applicant must not wear glasses in their photographs.
Passport MUST contain at least two blank visa pages in order for the visa to be issued.

The link for visa application is given below

Medical fee[IN DINAR]

Embassy of India
Address : 17, domaine CHEKIKEN (Chemin de la Madeleine), Val d’Hydra, Algiers
Postal Address : BP.108, El Biar, 16030 Algiers, Algeria
Tel. No. : 00213 23 47 25 21/76
Fax No. : 00213 23 47 29 04
Website :
E-mail :;
Working Hours : 0900 – 1730 hrs (Sunday-Thursday, except closed holidays)
Ambassador : SH. SATBIR SINGH
Ambassador’s Office    
  1. Attache/PS
: Smt. Anju Malik
  1. Attache/PS
: Sh. S.K.M. Hussaine
E-mail :

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

After amazing growth of CAR T-Cell therapy what's next
CAR T-Cell therapy

After amazing growth of CAR T-Cell therapy: what’s next?

CAR T-cell therapy has rapidly transformed cancer treatment by reprogramming a patient’s T-cells to attack cancer cells, demonstrating remarkable success in hematologic cancers. Advances in genetic engineering, regulatory support, and investment are driving further expansion. Researchers are now tackling the challenges of applying this therapy to solid tumors, aiming to enhance efficacy and accessibility, marking a new era in personalized cancer therapy and immunotherapy.

Lutetium Lu 177 dotatate is approved by USFDA for pediatric patients 12 years and older with GEP-NETS

Lutetium Lu 177 dotatate is approved by USFDA for pediatric patients 12 years and older with GEP-NETS

Lutetium Lu 177 dotatate, a groundbreaking treatment, has recently received approval from the US Food and Drug Administration (FDA) for pediatric patients, marking a significant milestone in pediatric oncology. This approval represents a beacon of hope for children battling neuroendocrine tumors (NETs), a rare but challenging form of cancer that often proves resistant to conventional therapies.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy